MedPath

An efficacy and safety of nano fractional radiofrequency for the treatment of striae alba

Phase 2
Completed
Conditions
Striae alba
Fractional radiofrequency
Nano fractional RF
Registration Number
TCTR20160907003
Lead Sponsor
Faculty of Medicine, Srinakharinwirot University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
33
Inclusion Criteria

age between 18-60 years, with skin type III or IV were diagnosed with striae alba at thigh, abdominal or buttock area

Exclusion Criteria

Subjects who were previously treated with any kind of lasers, RF, dermabrasion, microdermabrasion or chemical peeling within 6 months prior to the study.
Subjects who applied topical corticosteroids, retinoid, vitamin C or vitamin E within 3months prior to the study.
Subjects who orally took any of the following supplement or medications such as vitamin C, vitamin E, corticosteroids or retinoids within 3 months.
Subjects who were heavy tobacco smokers.
Subjects who had a history of hypertrophic scar or keloid.
Subjects who on pacemaker or have other metallic implants.
Subjects who have active skin lesions on the study area.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Surface area 12 weeks Pictzar software
Secondary Outcome Measures
NameTimeMethod
Width 12 weeks Caliper,Length 12 weeks Caliper
© Copyright 2025. All Rights Reserved by MedPath